Hepalatide not checked

Shanghai HEP Pharmaceutical Co., Ltd. · L47

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
6 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Continuous treatment with hepalatide 2.1mg sc, qd, for 48 weeks”In the company’s words, NCT07309380 on ClinicalTrials.gov
Tested for
Hepatitis D, Chronic
Main trialPhase 3
“This study adopts a multicenter, randomized, double-blind, placebo-parallel controlled design to evaluate the efficacy and safety of L47 in the treatment of chronic hepatitis D. A total of 150 subjects are planned to be enrolled. After passing the screening, they will be randomly assigned to the L47 group or the placebo group at a ratio of 2:1, with liver cirrhosis and subjects' regional distribution as stratification factors. The two groups will receive hepratide (2.1 mg/day) or placebo, respectively. Upon completion of the 48-week double-blind treatment phase, all subjects in each group…”In the company’s words, NCT07309380 on ClinicalTrials.gov
Other names
L47 · HLT

Other drugs for Hepatitis D, Chronic

All 6 drugs for Hepatitis D, Chronic

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting Jun 2028 Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D
Phase 2Completed 1 Nov 2023 A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
Phase 2Completed 30 Jan 2024 Study of Hepalatide in Chronic Hepatitis D(CHD) Patients
Phase 2Completed 24 Jun 2024 A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients
Phase 2Completed 1 May 2026 A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D
Phase 1/2Withdrawn Dec 2025 A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Hepalatide

Following is part of Solo: you see every change to Hepalatide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in